Prophylaxis of Venous Thromboembolic Events

Also known as: Prophylaxis, Thromboembolism, Venous / VTE Prophylaxis / Prophylaxis of VTE / Prophylaxis of Venous Thromboembolism / Venous thromboembolism prophylaxis / Anticoagulant prophylaxis / Prescription of prophylactic anticoagulant (procedure) / Thrombosis prophylaxis / Thromboembolism prophylaxis / Anticoagulant prophylaxis (procedure)

DrugDrug NameDrug Description
DB12364BetrixabanA Factor Xa inhibitor used for prophylaxis of venous thromboembolism in hospitalized patients.
DB06779DalteparinA low molecular weight heparin used for the prophylaxis of thrombotic events in certain patients and prevent acute cardiac ischemic events in patients with unstable angina and non-Q-wave myocardial infarction.
DB08813NadroparinA low molecular weight heparin used for the prophylaxis of thrombotic events and deep vein thrombosis, and prevent unstable angina and non-Q-wave myocardial infarction.
DB06228RivaroxabanA factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). May also be used as thrombosis prophylaxis in specific situations.
DB06822TinzaparinA low molecular weight heparin used for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin.
DrugDrug NamePhaseStatusCount
DB12364Betrixaban1Terminated1
DB06228Rivaroxaban1Completed2
DB06228Rivaroxaban2Completed1
DB06050TB-4022Completed1
DB06228RivaroxabanNot AvailableWithdrawn1